CNN: Quin puede tomarlos
Discussion The results of the current meta-analysis, that included 60,080 patients with T2DM, 14,804 of whom without established CV disease, demonstrate that GLP-1RA reduce the risk of MACE by 14% in the overall diabetic population, with an apparently greater effect in patients with known CV disease as compared with those without established CV disease (16% vs 6% reduction, respectively)
To view or add a comment, sign in Do GLP-1 Weight Loss Medications Really Work
For extra support with your GLP-1 treatment, you might want to check out TrimRX
Access research on the CagriSema combination, clinical trial data, and real-world protocols from early adopters
The recording was performed with a camera attached to a VMS-004 Discovery Deluxe USB microscope (Veho, United States) at the end of the experiment and assessed as before (Gojkovic et al., 2021a